Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$98 | -$66 | -$59 | -$51 |
| Dep. & Amort. | $2 | $2 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $3 | $2 | $0 |
| Change in WC | $3 | $1 | $2 | $6 |
| Other Non-Cash | -$0 | $1 | $0 | $0 |
| Operating Cash Flow | -$81 | -$59 | -$55 | -$44 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$94 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | -$0 | $0 |
| Investing Cash Flow | -$94 | -$0 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $4 | -$0 | $0 |
| Stock Issued | $89 | $100 | $0 | $0 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $151 |
| Financing Cash Flow | $89 | $104 | $0 | $151 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$86 | $44 | -$55 | $106 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $125 | $81 | $136 | $29 |
| End Cash | $38 | $125 | $81 | $136 |
| Free Cash Flow | -$82 | -$60 | -$55 | -$44 |